Taxus Cardium Pharmaceuticals Group (CRXM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 09-2005 | 06-2005 | 03-2005 | 12-2004 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 21,788 | N/A | 2,565 | 2,592 | 2,622 |
| Receivables | N/A | N/A | N/A | N/A | 12 |
| TOTAL | $21,958 | $N/A | $2,597 | $2,600 | $2,651 |
| Non-Current Assets | |||||
| PPE Net | 372 | N/A | N/A | N/A | N/A |
| Other Non-Current Assets | 22 | 0 | 0 | 0 | 0 |
| TOTAL | $394 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $22,352 | $N/A | $2,597 | $2,600 | $2,651 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 163 | 0 | 55 | 47 | 67 |
| Accrued Expenses | 451 | N/A | 19 | N/A | 3 |
| TOTAL | $614 | $N/A | $73 | $47 | $69 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $614 | $N/A | $73 | $47 | $69 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,587 | N/A | 102 | 102 | 102 |
| Common Shares | 3 | N/A | 33 | 33 | 33 |
| Retained earnings | -5,446 | N/A | 2,033 | 2,063 | 2,092 |
| Other shareholders' equity | 0 | 0 | -344 | -344 | -344 |
| TOTAL | $21,738 | $N/A | $2,523 | $2,553 | $2,582 |
| Total Liabilities And Equity | $22,352 | $0 | $2,597 | $2,600 | $2,651 |